Lv1
20 积分 2023-09-06 加入
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
2个月前
已完结
Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management
3个月前
已完结
The pathophysiology of MASLD: an immunometabolic perspective
4个月前
已完结
First US drug approved for a liver disease surging around the world
4个月前
已完结
Mechanisms and therapeutic insights into MASH-associated fibrosis
4个月前
已完结
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
4个月前
已完结
Serum amyloid A1–induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression
6个月前
已完结
GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver
7个月前
已完结
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
7个月前
已完结
Magnesium Disorders
7个月前
已完结
皖公网安备34019202002308
